Bruxism
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
RTT-associated features included the following: loss of hand or language skills (n = 3; IQSEC2, KCNB1 x 2); disrupted sleep (n = 4; KNCB1, MEIS2, TCF4, WDR45); stereotyped hand movements (n = 5; FOXG1, KNCB1 x 2, MEIS2, TCF4); bruxism (n = 3; KCNB1 x 2; TCF4); and hypotonia (n = 7).
|
29322350 |
2018 |
Rett Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
RTT-associated features included the following: loss of hand or language skills (n = 3; IQSEC2, KCNB1 x 2); disrupted sleep (n = 4; KNCB1, MEIS2, TCF4, WDR45); stereotyped hand movements (n = 5; FOXG1, KNCB1 x 2, MEIS2, TCF4); bruxism (n = 3; KCNB1 x 2; TCF4); and hypotonia (n = 7).
|
29322350 |
2018 |
Gram-Positive Bacterial Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
These data support further clinical development of oral MRX-I in the treatment of resistant Gram-positive bacterial infections.
|
28167545 |
2017 |
Narrowing
|
0.010 |
Biomarker
|
disease |
BEFREE |
The role of IQSEC2 in syndromic intellectual disability: Narrowing the diagnostic odyssey.
|
28815955 |
2017 |
Hyperactive behavior
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Taken together, the data suggest that gains in Xp11.22 including IQSEC2 cause ID and are associated with hyperactivity and attention-deficit/hyperactivity disorder, and are likely to be dosage-sensitive in males.
|
26059843 |
2016 |
Charcot-Marie-Tooth Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
A number of human neurological disorders have been mapped to the Xp22 region, including Aicardi syndrome (MIM 304050), Rett syndrome (MIM 312750), X-linked Charcot-Marie-Tooth neuropathy (MIM 302801), and X-linked mental retardation syndromes (MRX1, MIM 309530).
|
8661015 |
1996 |
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma.
|
8649811 |
1996 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
A number of human neurological disorders have been mapped to the Xp22 region, including Aicardi syndrome (MIM 304050), Rett syndrome (MIM 312750), X-linked Charcot-Marie-Tooth neuropathy (MIM 302801), and X-linked mental retardation syndromes (MRX1, MIM 309530).
|
8661015 |
1996 |
Aicardi's syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A number of human neurological disorders have been mapped to the Xp22 region, including Aicardi syndrome (MIM 304050), Rett syndrome (MIM 312750), X-linked Charcot-Marie-Tooth neuropathy (MIM 302801), and X-linked mental retardation syndromes (MRX1, MIM 309530).
|
8661015 |
1996 |
Developmental delay (disorder)
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
The IQSEC2 variant phenotype includes developmental delay, intellectual disability, epilepsy, hypotonia, autism, developmental regression, microcephaly and stereotypies but is yet to be fully described.
|
30666632 |
2019 |
Epileptic encephalopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Whole exome sequencing identified a truncating pathogenic variant in IQSEC2 at NM_001111125.2: c.2679_2680insA, p.(D894fs*10), a recently identified cause of epileptic encephalopathy in females (MIM 300522).
|
28295038 |
2017 |
Epileptic encephalopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Herein we characterize the epilepsy/epileptic encephalopathy of patients with IQSEC2 pathogenic variants.
|
27665735 |
2016 |
Developmental delay (disorder)
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
Here we report two novel IQSEC2 de novo truncating mutations identified through diagnostic exome sequencing in two severely affected unrelated male probands manifesting developmental delay, seizures, hypotonia, plagiocephaly, and abnormal MRI findings.
|
24306141 |
2014 |
Encephalopathies
|
0.030 |
Biomarker
|
group |
BEFREE |
Correction: IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients.
|
30279470 |
2019 |
Encephalopathies
|
0.030 |
Biomarker
|
group |
BEFREE |
IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients.
|
30206421 |
2019 |
Encephalopathies
|
0.030 |
GeneticVariation
|
group |
BEFREE |
An IQSEC2 nonsense variant was detected in the female ID patient, providing further evidence for a role of this gene in encephalopathy in females.
|
25649377 |
2015 |
Autism Spectrum Disorders
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
Targeted resequencing of 358 candidate genes for autism spectrum disorder in a Chinese cohort reveals diagnostic potential and genotype-phenotype correlations.
|
30763456 |
2019 |
Mild Mental Retardation
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability.
|
26733290 |
2016 |
Moderate intellectual disability
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability.
|
26733290 |
2016 |
Delayed speech and language development
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability.
|
26733290 |
2016 |
Learning Disabilities
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability.
|
26733290 |
2016 |
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft upper lip
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Constipation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|